Clinical Trial Update: Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 study of ExoFlo for medically refractory ulcerative colitis has been terminated; no efficacy results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• ExoFlo

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 1 | Status: TERMINATED